The effect of cholecalciferol supplementation on parathyroid hormone levels and bone loss at the lumbar spine in kidney transplant recipients was studied in a placebo-controlled trial.
Purpura and ulcers were the most frequent form of clinical presentation of calciphylaxis.
Study findings suggest serum phosphate is a negative modulator of calcium receptor activation.
A recent findings, if validated, may partly explain inter-individual differences in the response to cinacalcet treatment for secondary hyperparathyroidism.
Ultrasound-guided radiofrequency ablation may result in a shorter hospital stay compared with parathyroidectomy.
Elevated parathyroid hormone has been reported as a potential risk factor for cognitive impairment.
Hungry bone syndrome occurs in 1 of 5 patients after parathyroidectomy for secondary hyperparathyroidism of renal origin, a study found.
Magnesium homeostasis in CKD-MBD been the subject of increasing attention because it plays an important role in the pathophysiology of cardiovascular disease and bone health, according to investigators.
Paricalcitol and/or calcimimetic use is associated with improved survival in patients with COVID-19 receiving maintenance hemodialysis, a study found.
The medication inhibits bone resorption but is associated with prolonged elevation in PTH levels that require treatment.
